Use of targeted glycoproteomics to identify serum glycoproteins that correlate with liver cancer in woodchucks and humans
Timothy M. Block(Hepatitis B Foundation), Anand S. Mehta(Fox Chase Cancer Center), Mary Ann Comunale(Drexel University), Baruch S. Blumberg(Philadelphia University), Alison A. Evans(Fox Chase Cancer Center), Patrick R. Romano(Fox Chase Cancer Center), Claus J. Fimmel(Fox Chase Cancer Center), Raymond A. Dwek(University of Oxford), Melissa Lowman(Fox Chase Cancer Center), Bud C. Tennant(Fox Chase Cancer Center), W. Thomas London(Fox Chase Cancer Center), Laura F. Steel(Fox Chase Cancer Center), Tajinder S. Mattu(Fox Chase Cancer Center)
Cited by 370
Related Papers
A "New" Antigen in Leukemia Sera
|JAMA|1965|1.3k
A Serum Antigen (Australia Antigen) in Down's Syndrome, Leukemia, and Hepatitis
|Annals of Internal Medicine|1967|652
Particles associated with Australia Antigen in the Sera of Patients with Leukaemia, Down's Syndrome and Hepatitis
|Nature|1968|423
Comparison of the methods for profiling glycoprotein glycans—HUPO Human Disease Glycomics/Proteome Initiative multi-institutional study
|Glycobiology|2007|396
The hepatitis C virus p7 protein forms an ion channel that is inhibited by long-alkyl-chain iminosugar derivatives
|Proceedings of the National Academy of Sciences|2003|377